The Hanover Insurance
THG
217.61
-2.43
-1.10%
The Hanover Insurance
US · THG
#1711 by market cap
Listed 1970
217.61
-2.43
-1.10%
Live - 5344 symbols - heartbeat 262s ago
· 2026-10-08 07:37
Pre-market
217.61
0.00%
After-hours
217.80
+0.09%
- Market cap
- 7.58B
- P/E (TTM)i
- 10.39
- P/Bi
- 2.06
- EPSi
- 18.16
- Div yieldi
- 1.72%
- 52W posi
- 76%
Reader sentiment
Are you bullish or bearish on THG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 92.51% +0.06pp
- Institutions
- 611 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund78.02%
Hedge Fund7.37%
Public Company2.01%
Government Pension Fund1.71%
Sovereign Wealth Fund1.29%
Individual/Insider0.95%
Insurance Company0.92%
Private Company0.73%
Family Office/Trust0.30%
Other6.71%
Top holders as of 2026-06-30
BlackRock
10.15% · 3.53M sh
Vanguard Portfolio Management, LLC
5.51% · 1.92M sh
T. Rowe Price Group, Inc.
5.51% · 1.92M sh
Vanguard Capital Management, LLC
4.82% · 1.68M sh
State Street Global Advisors
4.67% · 1.63M sh
AQR Capital Management
3.83% · 1.33M sh
Fuller & Thaler Asset Management, Inc.
3.13% · 1.09M sh
American Century Investment Management
3.10% · 1.08M sh
Dimensional Fund Advisors
2.96% · 1.03M sh
AllianceBernstein
2.61% · 909.13K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 37 buys · 13 sells
| Name | Role | Stake |
|---|---|---|
| John Roche | Chief Executive Officer | 0.36% |
| Jeffrey Farber | Chief Financial Officer | 0.17% |
| Joseph Ramrath | Independent Director | 0.09% |
| Richard Lavey | Executive VP & President of Hanover Agency Markets | 0.08% |
| Bryan Salvatore | Executive VP & President of Specialty | 0.07% |
| Cynthia Egan | Independent Chairperson & Independent Presiding Director | 0.03% |
| Kevin Bradicich | Independent Director | 0.03% |
| Dennis Kerrigan | Executive VP, Assistant Secretary & Chief Legal Officer | 0.02% |
| Willard Lee | Executive VP, Chief Information & Innovation Officer | 0.02% |
| James Condrin | Independent Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-24 | Joseph Ramrath | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Kathleen Lane | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Theodore Bunting | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Jeffrey Farber | Chief Financial Officer | Other Acquisition | +41 | -- |
| 2026-09-24 | Richard Lavey | Executive VP & President of Hanover Agency Markets | Other Acquisition | +27 | -- |
| 2026-09-24 | William Donnell | Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Elizabeth A. Chicares | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Cynthia Egan | Independent Chairperson & Independent Presiding Director | Other Acquisition | +3 | -- |
| 2026-09-24 | John Roche | Chief Executive Officer | Other Acquisition | +120 | -- |
| 2026-09-24 | Bryan Salvatore | Executive VP & President of Specialty | Other Acquisition | +24 | -- |
| 2026-09-24 | Dennis Kerrigan | Executive VP, Assistant Secretary & Chief Legal Officer | Other Acquisition | +14 | -- |
| 2026-09-24 | James Condrin | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Francisco Aristeguieta Silva | Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Jane Carlin | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | David Lovely | Executive VP & Chief Claims Officer | Other Acquisition | +10 | -- |
| 2026-09-24 | Kevin Bradicich | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Willard Lee | Executive VP, Chief Information & Innovation Officer | Other Acquisition | +10 | -- |
| 2026-09-24 | Patricia Norton-Gatto | Senior VP, Corporate Controller & Principal Accounting Officer | Other Acquisition | +5 | -- |
| 2026-09-15 | Denise Tinger Lowsley | Executive Vice President | Intent to Sell (Form 144) | -9,864 | $231.18 |
| 2026-08-19 | Dennis Kerrigan | Executive VP, Assistant Secretary & Chief Legal Officer | Derivative Exercise and Sale | -8,655 | $118.54–222.97 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:37:42 · For reference only, not investment advice and not tailored to your situation.